Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

Krazati and Erbitux Combo Benefits KRAS G12C+ Metastatic Colorectal Cancer

February 20th 2025, 4:00pm

Video

Dr. Nataliya Uboha explained the benefit of treatment with Krazati combined with Erbitux in KRAS G12C–mutant metastatic colorectal cancer.

Breaking Down The Importance of Targeted Therapies in Colorectal Cancer Care

February 11th 2025, 8:00pm

Video

Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.

Lonsurf Shows Survival Benefit Over Placebo in Stage 4 Colorectal Cancer

February 10th 2025, 2:00pm

Article

In patients with residual disease after curative resection of colorectal cancer, Lonsurf showed a numerical improvement in DFS, though not significant.

Braftovi Plus Erbitux With mFOLFOX6 May Improve Responses in BRAF V600E+ mCRC

February 8th 2025, 3:00pm

Article

Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.

Lumakras Combo May Replace SOC in Third-Line Treatment for mCRC

February 6th 2025, 8:00pm

Article

Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated metastatic colorectal cancer.

Krazati and Erbitux Effective for KRAS G12C-Mutant Advanced mCRC

February 6th 2025, 2:00pm

Article

Findings presented at the Gastrointestinal Cancers Symposium showed the efficacy of Krazati and Erbitux for some patients with unresectable or metastatic colorectal cancer.

Palliative Care May Reduce Invasive Intervention Use in Early-Onset CRC

February 5th 2025, 2:00pm

Article

Palliative care for young adults with colorectal cancer reduced invasive procedures, costs and increased DNR orders.

Rybrevant Alone and in Combo With Chemo is Efficacious in Wildtype+ mCRC

February 3rd 2025, 8:00pm

Article

Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.

Breaking Down Cancer Therapies Approved by the FDA in January 2025

February 3rd 2025, 4:00pm

Article

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.

Opdivo Plus Yervoy Improves Outcomes in Metastatic Colorectal Cancer Subset

January 29th 2025, 8:00pm

Article

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic colorectal cancer.